HH&L Acquisition Co. announced the pricing of its upsized $360 million IPO this evening and its units are expected to begin trading on the NYSE under the symbol “HHLA.U” Friday, February 5.
The new company aims to combine with a high-growth healthcare business in Asia with a focus on China. HH&L is led by Chairman Kenneth W. Hitchner, CEO Richard Qi Li, COO Huanan Yang, and CFO Yingjie Zhong.
Total SPAC deal count for 2021 year-to-date is now 117 with $34.8 billion in gross proceeds raised. This offering is expected to close on Tuesday, February 9.
Goldman Sachs (Asia) LLC and Credit Suisse Securities (USA) LLC are acting as book-running managers for the offering. White & Case LLP is serving as Issuer’s Counsel with Skadden, Arps, Slate, Meagher & Flom LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.